cp 66713 has been researched along with glucose, (beta-d)-isomer in 1 studies
Studies (cp 66713) | Trials (cp 66713) | Recent Studies (post-2010) (cp 66713) | Studies (glucose, (beta-d)-isomer) | Trials (glucose, (beta-d)-isomer) | Recent Studies (post-2010) (glucose, (beta-d)-isomer) |
---|---|---|---|---|---|
22 | 0 | 4 | 21,956 | 883 | 10,747 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fredholm, BB; Hedqvist, P; Raud, J; Zhang, Y | 1 |
1 other study(ies) available for cp 66713 and glucose, (beta-d)-isomer
Article | Year |
---|---|
Propentofylline inhibits polymorphonuclear leukocyte recruitment in vivo by a mechanism involving adenosine A2A receptors.
Topics: Animals; Anti-Ulcer Agents; Male; Mice; Neutrophils; Peritonitis; Purinergic P1 Receptor Antagonists; Pyrazines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Xanthines; Zymosan | 1996 |